MOQ- 5000 vials.
Formulation No TPVFM008
Enrofloxacin Injection is used to treat difficult infections, including those caused by Pseudomonas and Staphylococci. Enrofloxacin is most often used to combat skin and ear infections in dogs and cats and respiratory and urinary infections in dogs.
Enrofloxacin works by deactivating the bacterial enzymes needed for DNA transcription and is effective against both gram-negative and gram-positive bacteria.
It is important to note that AdvaCare’s enrofloxacin liquid injection is for veterinary purposes only, and altho’ there are similar medications available for human consumption, you should only use medications prescribed by a veterinary doctor or animal care specialist for an animal.
As with all veterinary medicine, some unwanted effects can occur from the use of enrofloxacin. Always consult a veterinary physician or animal care specialist for medical advice before use.
Side effects are not typically associated with enrofloxacin unless the dose used is high. Nausea, vomiting, and diarrhea may occur at roughly ten times the recommended dose, which is sometimes needed to treat ear infections. Other enrofloxacin side effects are less common and may include loss of appetite, lethargy, convulsions, cataracts (with long-term use), and seizures (in pets with existing CNS disorders).
Joint damage can occur in immature dogs undergoing treatment with enrofloxacin. For this reason, the medication should not be used in puppies less than 8 months of age unless absolutely necessary. Additionally, enrofloxacin use can cause crystals to develop in urine. These crystals may show on laboratory testing.
Enrofloxacin should not be used in animals with a known allergy or hypersensitivity to the drug. Any known or suspected overdose requires prompt veterinarian attention.
For a comprehensive list of all possible effects, consult a veterinary physician.
If any symptom persists or gets worse, or you notice any other symptom, then please seek veterinary medical treatment immediately.
There are no inquiries yet.